MariMed Inc. (MRMD) Reports In-Line Q4 EPS; Offers Guidance

MariMed Inc. (OTC: MRMD) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $35.83 million versus the consensus estimate of $35.1 million.

GUIDANCE:

MariMed Inc. sees FY2023 revenue of $150+ million, versus the consensus of $152.8 million.

For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• L3Harris CEO steps down amid conduct review, shares drop
• Is Treasury selloff a major issue for stock market bulls?